Galenica AG
SWB:G70
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Galenica AG (G70) under the Base Case is 109.15 EUR per share.
Compared with the current market price of 98.1 EUR, the stock appears
Undervalued by 10% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Galenica Does
Galenica AG is a Swiss healthcare company focused on moving medicines and health products to the people and businesses that need them. It runs a large pharmacy network, distributes prescription drugs and over-the-counter products, and supplies medicines, medical goods, and related services to pharmacies, doctors, hospitals, and care institutions in Switzerland.
- Headquarters
- Switzerland CH
- Employees
- 6 577
- IPO date
- Apr 7, 2017
Balance Sheet
Continue G70 Research
Decided on Galenica? Get an email when G70 reaches the price you’d buy at. Free with an account.
Other Galenica listings
What is the Intrinsic Value of one G70 stock?
The intrinsic value for
Galenica AG (G70) under the Base Case is 109.15 EUR.
Is G70 stock undervalued or overvalued?
Compared with the current market price of 98.1 EUR, the stock appears Undervalued by 10% .